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Abstract
Background: A prospective cohort study was set up to investigate a possible association between antibiotic
prescribing and antibiotic resistance of E. coli urinary tract infection in the community. Participation of patients with
urinary tract infection was obtained through an opt-out methodology. This short paper reports on the acceptability
of the opt-out recruitment approach.
Methods: Participating practices (22) were requested to send a urine sample from all patients presenting with
symptoms of urinary tract infection. Upon receipt of the sample in the laboratory, a letter explaining the study, an
opt-out form and a freepost envelope were sent to all adult patients. A website with additional information and
including an ‘opt-out’ button was set up for the study.
Results: A total of 1362 urine samples were submitted by the 22 participating practices representing 1178 adult
patients of whom 193 actively responded to the letter: 142 opted out by letter, 15 through the website, 2 by
phone and 12 sent the letter back without indication, making a total of 171 patients or 14.5% opt-out; the
remaining 22 patients (1.9%) explicitly opted in. The total group consisted of 80% women and the mean age was
50.9 years (sd 20.8). No significant differences were found between patients who participated and those who
opted out in terms of age, gender or whether the urine sample was positive or not.
Conclusions: Overall the opt-out method was well received and participation in the study reached 85.5%. The low
number of complaints (2) indicates that this is a generally acceptable method of patient recruitment. The 14.5%
opt-out shows that it effectively empowers patients to decline participation. The similarity between patients opting
out and the rest of the patients is reassuring for extrapolation of the results of the study.
Background
The gold standard with respect to ethical recruitment of
participants in research is explicit written consent,
although various studies have shown that most patients
do not have a preference for active consent [1]. An Irish
study on public perceptions of biomedical research
found that the public is generally aware of and com-
mitted to making a contribution to research and related
activities in the healthcare system for their benefit and
for the benefit of future patients [2]. In our study on
management of urinary tract infection (UTI) in general
practice, it was important to get a representative sample
of patients. Concern was raised that an opt-in method
for recruitment could cause bias as this approach is
time consuming for the general practitioner (GP) which
could impact on the participation of the GP and the
patient. This short paper gives an overview of the appli-
cation of an opt-out recruitment approach and its
acceptability for consideration in other health-related
studies.
Overview of the justification to support opt-out consent
Active consent or opt-in has been shown to limit parti-
cipation [3] and introduce bias into studies [4]. If con-
sent is considered an indication of willingness rather
than refusal and if risks for the participants are very
low, an opt-out arrangement or passive consent is gen-
erally the most efficient procedure without violating the
option of providing choice [5]. This methodology will
most likely result in a more representative population
reflecting the real life situation [6].
A limited number of studies explicitly researched pos-
sible objections to the opt-out system and not only
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tionally identified patients’ appreciation of participation
in research [7,8].
Good methodology should respect personal autonomy
by providing the necessary information to make an
informed decision and include safeguards to protect
privacy [9-11]. The challenge in applying an opt-out
methodology is to provide easily accessible information
to all patients to facilitate informed consent without
interfering with the medical consultation. This principle
was applied to our study on antimicrobial resistance and
prescribing in adults with urinary tract infections.
Methods
A prospective cohort study was set up to describe the
management of UTI in Irish general practice as well as
to investigate a possible association between antimicro-
bial prescribing and resistance of E. coli isolated from
patients with urinary tract infection.
Following extensive dialogue with the Research Ethics
Committee of the Irish College of General Practitioners,
approval for an opt-out consent method was given. The
study received ethical approval for the use of an opt-out
methodology based on the low risk to the patient and
the potential benefit for the patient of adequate manage-
ment of UTI based on unbiased information [5,12]. In
this interpretation consent is an indication of willingness
rather than refusal and informed consent is obtained by
generally accessible information as well as easy modes
to opt out [11].
Only one laboratory provides microbiological services
in this region. After a retrospective analysis of laboratory
data from all practices submitting to this laboratory [13],
a list of practices was generated based on the number of
positive urine samples in 2007. In an effort to limit the
workload of a potential increase in the number of sam-
ples due to the study and in consultation with the
laboratory, the highest ranking practices were selected.
The top 25 practices were invited and 22 agreed to par-
ticipate in the study, two practices did not have compu-
terised records and one practice declined. Practices were
located in rural as well as urban locations with a variety
of patient populations. Practices had different patient
(age and gender) profiles as well as different proportions
of private and medical card patients. At the time of the
study about 30% of the population was eligible for a
medical card. Medical card eligibility is determined by
income as well as age (all pensioners over the age of
70 years are eligible). Medical card patients have free
medical care and medication [14]. The participating
general practices were considered representative of all
Irish general practices.
All practices received posters informing patients of the
study to display in the waiting room, as well as little
reminder cards for the consultation rooms. Participating
practices were requested to send a urine sample from all
patients presenting with symptoms suggestive of urinary
tract infection. Upon receipt of the sample in the
laboratory, a letter explaining the study (supplementary
file), an opt-out form and a freepost envelope were sent
to all adult patients who supplied a urine sample.
In the letter patients were informed of the objectives
of the study and permission for the researcher to look
at their GP records was requested. Additionally, it was
explained that they were free to opt out of participation
in the study by filling out the included opt-out form, by
phone or through the website.
A dedicated website was set up with detailed informa-
tion on the study as well as on the problem of antimi-
crobial resistance in general http://www.antibiotics.
nuigalway.ie. The index page included an ‘opt-out’ but-
ton which linked to a form that could be filled out by
the patient. The website was clearly laid out to avoid
confusion and ensure easy opt-out. Regular updates on
the study, as well as study results were added to the
website when available.
Results
A total of 1362 urine samples were submitted by the 22
participating practices during the study period. The
samples were from 1178 adult patients. The 22 practices
sent in between 15 and 115 samples.
In total 193 patients actively responded to the letter:
142 opted out by letter, 15 through the website, 2 by
phone and 12 sent the letter back without indication,
making a total of 171 patients (14.5%) who opted
out; the remaining 22 patients (1.9%) explicitly opted in
(Figure 1). The letters of 24 patients had a wrong
address and were returned.
Two patients expressed concerns regarding the use of
the opt-out method. Both questioned the way their
address was obtained and whether this interfered with
the confidentiality of their patient data. An individual
response to these concerns was sent to their GP with a
request to forward this to the patient. No further con-
cerns were expressed.
Patients consisted of 941 women (79.9%) and 237 men
(20.1%). Their mean age was 50.9 years (sd 20.8) and
the median age was 47 years. Patients who opted out
were slightly older (52.8 vs 50.4 years) and the percen-
tage of females was slightly higher (83% vs 79.5%) but
these differences were not statistically significant.
Patients who opted out through the website were signifi-
cantly younger than those who used the letter (non-
parametric, 53.5 vs 38.7 years, p < 0.05).
A significant isolate (pure culture at greater than 10
5
colony forming units/ml) was identified from the urine
sample of 402 (34.1%) patients. Patients with a positive
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those with a negative culture.
Discussion and Conclusions
Overall the opt-out method was well received by both
general practitioner and patients and achieved a high
level of participation in the study at 83.4%. The low
number of complaints indicates that this is a generally
acceptable method of patient recruitment. The 14.5%
opt-out of patients shows that the process effectively
empowered patients to decline participation. The high
similarity between patients opting out and the partici-
pating patients with respect to age, gender and isolation
of a positive culture is reassuring for extrapolation of
the results of the study. However, as no other potentially
important variables were available about the patients
who opted out, it cannot be ruled out that other factors
were of importance for participation in the study. Simi-
larly, even though every effort was made to inform
patients of the study, it cannot be guaranteed that all
patients received this information through the different
media offered by us.
Our findings are in line with other studies which have
shown that an opt-out methodology is generally well
accepted and will result in high participation rates
[7,8,15]. A recent Cochrane review looked at ways to
increase recruitment into clinical studies and also identi-
fied opt- out as a possible method [16]. The lack of
Figure 1 Flow chart of the participation and opt-out of patients in the study.
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general practitioners, acknowledged in the ethical
approval given to the study, favours this type of recruit-
ment which might be less applicable for studies with
more involvement or risk. For non-interventional, low-
risk studies in which rigorous measure to inform
patients and protect patient confidentiality are in place,
recruitment by opt-out is an easy and acceptable metho-
dology for patients, GPs and researchers. As earlier sta-
ted by Junghans et al. [4], the opt-out approach should
be the default recruitment strategy for studies with low
risk to participants.
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